Status:
RECRUITING
Role of Low Dose Injectable Progesterone in Triggering Ovulation
Lead Sponsor:
The General Authority for Teaching Hospitals and Institutes
Conditions:
Low Dose
Progesterone
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.
Detailed Description
Infertility affects approximately 10-15% of couples attempting pregnancy, with no readily identifiable cause found in 15-30% of these patients, resulting in a diagnosis of unexplained infertility. Ko...
Eligibility Criteria
Inclusion
- Age from 20 to 35 years.
- Infertile women.
- Basal follicle-stimulating hormone (FSH) level \<10 mIU/ml.
Exclusion
- Poor ovarian reserve.
- Immunological disease.
- Endometriosis.
- Uterine abnormality.
- Body mass index (BMI) \>30 kg/m2.
- Endometrial thickness \<8 or \>12 mm on the day of triggering.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06928844
Start Date
April 15 2025
End Date
August 1 2025
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teaching Hospitals and Institutes
Cairo, Egypt